Federal Register / Vol. 80, No. 73 / Thursday, April 16, 2015 / Notices 20497 

PERSON TO CONTACT FOR INFORMATION: 

Judith Ingram, Press Officer, Telephone: 

(202) 694–1220. 

Shawn Woodhead Werth, 

Secretary and Clerk of the Commission. 

[FR Doc. 2015–08906 Filed 4–14–15; 4:15 pm] 

BILLING CODE 6715–01–P 

FEDERAL RESERVE SYSTEM 

Notice of Proposals To Engage in or 

To Acquire Companies Engaged in 

Permissible Nonbanking Activities; 

Correction 

This notice corrects a notice (FR Doc. 

2015–08045) published on pages 18442 

and 18443 of the issue for Wednesday, 

April 8, 2015. 

Under the Federal Reserve Bank of 

San Francisco heading, the entry for 

Cathay Financial Holding Co., Ltd., 

Taipei, Taiwan, is revised to read as 

follows: 

A. Federal Reserve Bank of San 

Francisco (Gerald C. Tsai, Director, 

Applications and Enforcement) 101 

Market Street, San Francisco, California 

94105–1579: 

1. Cathay Financial Holding Co., Ltd., 

Cathay Life Insurance Co., Ltd., Liang 

Ting Industrial Co., Ltd., Lin Yuan 

Investment Co., Ltd., Pai Hsing 

Investment Co., Ltd., Tung Chi Capital 

Co., Ltd., and Wan Ta Investment Co., 

Ltd., all in Taipei, Taiwan, and Wan 

Bao Development Co., Ltd., New Taipei, 

Taiwan; to acquire Conning Holdings 

Corp., Hartford, Connecticut, and 

thereby engage in financial and 

investment advisory activities, and 

agency transactional services for 

customer investments, pursuant to 

sections 225.28(b)(6) and (b)(7). 

Comments on this application must 

be received by April 23, 2015. 

Board of Governors of the Federal Reserve 

System, April 13, 2015. 

Michael J. Lewandowski, 

Associate Secretary of the Board. 

[FR Doc. 2015–08713 Filed 4–15–15; 8:45 am] 

BILLING CODE 6210–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[CDC–2014–0013; Docket Number NIOSH– 

274] 

Issuance of Final Guidance Publication 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH) of the Centers for Disease 

Control and Prevention (CDC), 

Department of Health and Human 

Services (HHS). 

ACTION: Notice of issuance of final 

guidance publication. 

SUMMARY: The National Institute for 

Occupational Safety and Health 

(NIOSH) of the Centers for Disease 

Control and Prevention (CDC), 

announces the availability of the 

following publication: ‘‘NIOSH Current 

Intelligence Bulletin 67: Promoting 

Health and Preventing Disease and 

Injury through Workplace Tobacco 

Policies’’ [2015–113]. 

ADDRESSES: This document may be 

obtained at the following link: http://

www.cdc.gov/niosh/docs/2015-113/. 

FOR FURTHER INFORMATION CONTACT: 

Michelle Martin, NIOSH Division of 

Respiratory Disease Studies, 1095 

Willowdale Road, Mailstop H–2900, 

Morgantown, WV 26505–2888. (304) 

285–5734 (not a toll free number). 

Dated: April 9, 2015. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health, Centers for Disease Control 

and Prevention. 

[FR Doc. 2015–08737 Filed 4–15–15; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Proposed Information Collection 

Activity; Comment Request 

Proposed Projects: Immediate Disaster 

Case Management Intake Assessment 

(hardcopy and electronic versions). 

Title: Immediate Disaster Case 

Management Intake Assessment. 

OMB No.: 0970–NEW. 

Description: Section 426 of the Robert 

T. Stafford Disaster Relief and 

Emergency Assistance Act (Stafford 

Act), as amended, 42 U.S.C. 5189d 

authorizes the Federal Emergency 

Management Agency (FEMA) and the 

U.S. Department of Health Services’ 

Administration for Children and 

Families (ACF) to provide Immediate 

Disaster Case Management (IDCM) 

services under the federal Disaster Case 

Management Program (DCMP). 

The use of the Electronic Case 

Management Record System (ECMRS) is 

aligned with Executive Order of the 

President 13589 and the memorandum 

to the Heads of Executive Departments 

and Agencies M–12–12 from the Office 

of Management and Budget to ‘‘Promote 

Efficient Spending to Support Agency 

Operations.’’ 

The primary purpose of the 

information collection pertains to ACF/ 

OHSEPR’s initiative to improve the 

intake process and delivery of case 

management services to individuals and 

households impacted by a disaster. 

Further, the information collection will 

be used to support ACF/OHSEPR’s goal 

to quickly identify critical gaps, 

resources, needs, and services to 

support State, local and non-profit 

capacity for disaster case management 

and to augment and build capacity 

where none exists. All information 

gathered will be exclusively used to 

inform the delivery of disaster case 

management services and programmatic 

strategies and improvements. 

Respondents: Individuals impacted by 

a disaster. 

ANNUAL BURDEN ESTIMATES

Instrument Number of 

respondents 

Number of 

responses per 

respondent 

Burden hours 

per response 

Total burden 

hours 

IDCM Intake Assessment ................................................................................ 3,500 1 40 2,333 

Estimated Total Annual Burden 

Hours: 2,333 hours or 140,000 minutes 

In compliance with the requirements 

of Section 506(c)(2)(A) of the Paperwork 

Reduction Act of 1995, the 

Administration for Children and 

Families is soliciting public comment 

on the specific aspects of the 


tkelley on DSK3SPTVN1PROD with NOTICES
20498 Federal Register / Vol. 80, No. 73 / Thursday, April 16, 2015 / Notices 

information collection described above. 

Copies of the proposed collection of 

information can be obtained and 

comments may be forwarded by writing 

to the Administration for Children and 

Families, Office of Planning, Research 

and Evaluation, 370 L’Enfant 

Promenade SW., Washington, DC 20447, 

Attn: ACF Reports Clearance Officer. 

Email address: infocollection@

acf.hhs.gov. All requests should be 

identified by the title of the information 

collection. 

The Department specifically requests 

comments on: (a) Whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

the quality, utility, and clarity of the 

information to be collected; and (d) 

ways to minimize the burden of the 

collection of information on 

respondents, including through the use 

of automated collection techniques or 

other forms of information technology. 

Consideration will be given to 

comments and suggestions submitted 

within 60 days of this publication. 

Robert Sargis, 

Reports Clearance Officer. 

[FR Doc. 2015–08684 Filed 4–15–15; 8:45 am] 

BILLING CODE 4184–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2011–N–0672] 

Agency Information Collection 

Activities; Submission for Office of 

Management and Budget Review; 

Comment Request; Prominent and 

Conspicuous Mark of Manufacturers 

on Single-Use Devices 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing 

that a proposed collection of 

information has been submitted to the 

Office of Management and Budget 

(OMB) for review and clearance under 

the Paperwork Reduction Act of 1995. 

DATES: Fax written comments on the 

collection of information by May 18, 

2015. 

ADDRESSES: To ensure that comments on 

the information collection are received, 

OMB recommends that written 

comments be faxed to the Office of 

Information and Regulatory Affairs, 

OMB, Attn: FDA Desk Officer, FAX: 

202–395–7285, or emailed to oira_

submission@omb.eop.gov. All 

comments should be identified with the 

OMB control number 0910–0577. Also 

include the FDA docket number found 

in brackets in the heading of this 

document. 

FOR FURTHER INFORMATION CONTACT: FDA 

PRA Staff, Office of Operations, Food 

and Drug Administration, 8455 

Colesville Rd., COLE–14526, Silver 

Spring, MD 20993–0002, PRAStaff@

fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: In 

compliance with 44 U.S.C. 3507, FDA 

has submitted the following proposed 

collection of information to OMB for 

review and clearance. 

Prominent and Conspicuous Mark of 

Manufacturers On Single-Use Devices 

(OMB Control Number 0910–0577)— 

Extension 

Section 502 of the Federal Food, Drug, 

and Cosmetic Act (the FD&C Act) (21 

U.S.C. 352), among other things, 

establishes requirements that the label 

or labeling of a medical device must 

meet so that it is not misbranded and 

subject to regulatory action. Section 301 

of the Medical Device User Fee and 

Modernization Act of 2002 (Pub. L. 107– 

250) amended section 502 of the FD&C 

Act to add section 502(u) to require 

devices (both new and reprocessed) to 

bear prominently and conspicuously the 

name of the manufacturer, a generally 

recognized abbreviation of such name, 

or a unique and generally recognized 

symbol identifying the manufacturer. 

Section 2(c) of the Medical Device 

User Fee Stabilization Act of 2005 (Pub. 

L. 109–43) amends section 502(u) of the 

FD&C Act by limiting the provision to 

reprocessed single-use devices (SUDs) 

and the manufacturers who reprocess 

them. Under the amended provision, if 

the original SUD or an attachment to it 

prominently and conspicuously bears 

the name of the manufacturer, then the 

reprocessor of the SUD is required to 

identify itself by name, abbreviation, or 

symbol in a prominent and conspicuous 

manner on the device or attachment to 

the device. If the original SUD does not 

prominently and conspicuously bear the 

name of the manufacturer, the 

manufacturer who reprocesses the SUD 

for reuse may identify itself using a 

detachable label that is intended to be 

affixed to the patient record. 

The requirements of section 502(u) of 

the FD&C Act impose a minimal burden 

on industry. This section of the FD&C 

Act only requires the manufacturer, 

packer, or distributor of a device to 

include their name and address on the 

labeling of a device. This information is 

readily available to the establishment 

and easily supplied. From its 

registration and premarket submission 

database, FDA estimates that there are 

67 establishments that distribute 

approximately 427 reprocessed SUDs. 

Each response is anticipated to take 0.1 

hours (6 minutes) resulting in a total 

burden to industry of 43 hours. 

In the Federal Register of December 

30, 2014 (79 FR 78445), FDA published 

a 60-day notice requesting public 

comment on the proposed collection of 

information. No comments were 

received. 

FDA estimates the burden of this 

collection of information as follows: 

TABLE 1—ESTIMATED ANNUAL THIRD-PARTY DISCLOSURE BURDEN 1 2

Type of respondent Number of 

respondents 

Number of 

disclosures 

per respondent 

Total annual 

disclosures 

Average 

burden per 

disclosure 

Total hours 

Establishments listing fewer than 10 SUDs ....................... 58 2 116 0.1 (6 minutes) 12 

Establishments listing 10 or more SUDs ............................ 9 34 306 0.1 (6 minutes) 31 

Total ............................................................................. ...................... ............................ ........................ ......................... 43 

1There are no capital costs or operating and maintenance costs associated with this collection of information. 

2 Numbers have been rounded. 


tkelley on DSK3SPTVN1PROD with NOTICES